The utility of telephone helpline data for real-time syndromic surveillance of adverse events following immunization: Retrospective evaluation

被引：0
|
作者：
Mesfin, Y. [1 ]
Buttery, J. [2 ]
Cheng, A. [1 ]
机构：
[1] Monash Univ, Epidemiol & Prevent Med, Melbourne, Vic, Australia
[2] Monash Univ, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2020年 / 101卷
关键词：
D O I：
10.1016/j.ijid.2020.09.1073
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
0990
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [41] Real-World Data Obtained from Active Surveillance of Adverse Events Following Vaccination with COVID-19 Vaccines Using the Mobile App SafeVac 2.0
    Kopp, Larissa
    Mentzer, Dirk
    DRUG SAFETY, 2024, 47 (12) : 1326 - 1326
  • [42] A Simulated Prospective Evaluation and Comparison of a Deep Learning Model for Real-Time Prediction of Adverse Outcomes from Electronic Health Record Data
    Shah, P.
    Ginestra, J. C.
    Ungar, L. H.
    Junker, P.
    Rohrbach, J. I.
    Fishman, N.
    Weissman, G. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines
    Siddiqi, Danya Arif
    Abdullah, Sara
    Dharma, Vijay Kumar
    Shah, Mubarak Taighoon
    Akhter, Mohammed Adil
    Habib, Ali
    Khan, Aamir Javed
    Chandir, Subhash
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2021, 149
  • [44] Comparative Evaluation of Adverse Events Associated with Subcutaneous Infliximab (CT-P13 SC) and Intravenous Infliximab: A Real-world Analysis of Post-marketing Surveillance Data
    Baraliakos, Xenofon
    Kyburz, Diego
    Avouac, Jerome
    Barkham, Nick
    Lee, Soohyun
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3495 - 3498
  • [45] Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events
    Yaju, Yukari
    Tubaki, Hiroe
    JAPAN JOURNAL OF NURSING SCIENCE, 2020, 17 (01)
  • [46] Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019-2023
    Stefanizzi, Pasquale
    Di Lorenzo, Antonio
    Martinelli, Andrea
    Moscara, Lorenza
    Stella, Paolo
    Ancona, Domenica
    Tafuri, Silvio
    VACCINE, 2023, 41 (48) : 7096 - 7102
  • [47] Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a large-scale, multicentre, multinational, retrospective study
    Terkola, R.
    Czejka, M.
    Berube, J.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (04) : 446 - 453
  • [48] The safety of pneumococcal vaccines at the time of sequential schedule: data from surveillance of adverse events following 13-valent conjugated pneumococcal and 23-valent polysaccharidic pneumococcal vaccines in newborns and the elderly, in Puglia (Italy), 2013-2020
    Di Lorenzo, A.
    Martinelli, A.
    Bianchi, F. P.
    Scazzi, F. L.
    Diella, G.
    Tafuri, S.
    Stefanizzi, P.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2023, 35 (04): : 459 - 467
  • [49] Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Pappot, Helle
    Baeksted, Christina
    Knoop, Ann
    Mitchell, Sandra A.
    Nissen, Aase
    Johansen, Christoffer
    BREAST JOURNAL, 2019, 25 (02): : 269 - 272
  • [50] The effect of surveillance for symptomatic toxicities with real-time clinician reporting on dose reduction, hospitalization and febrile neutropenia in Danish breast cancer patients-a population-based cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Pappot, H.
    Baeksted, C.
    Nissen, A.
    Knoop, A.
    Mitchell, S.
    Christensen, J.
    Johansen, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S52 - S52
12345